Ultralytics
Ultralytics Raises $30M in Series A
Ultralytics Raises $30M in Series A
Ultralytics has successfully raised $30M in a Series A led by Elephant VC.
Company Overview
Ultralytics is a AI/ML company headquartered in Los Angeles, CA, founded in 2020 with 50+ employees.
Computer vision AI platform powering object detection for enterprises
Fundraising Details
- Amount Raised: $30M
- Round Type: Series A
- Date: 2025-09-20
- Investors: Elephant VC
About Ultralytics
Computer vision AI platform powering object detection for enterprises The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Los Angeles, CA
- Founded: 2020
- Team Size: 50+
- Industry: AI/ML
What This Means
This funding round demonstrates strong investor confidence in Ultralytics's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Ultralytics's successful fundraising reflects the strong fundamentals and growth potential in this space.
Looking Ahead
With this new capital, Ultralytics is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-09-20. For more information about Ultralytics, visit their headquarters at Los Angeles, CA.
Company Info
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free